Vaxart, Inc. Amortization of Intangible Assets
Vaxart, Inc. (VXRT) reported Amortization of Intangible Assets of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- Vaxart, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $200.00K, a 0.00% change year-over-year.
- Vaxart, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $200.00K, a 0.00% change year-over-year.
- Vaxart, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $200.00K, a 0.00% change year-over-year.
- Vaxart, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- Vaxart, Inc. amortization of intangible assets for fiscal 2024 was $700.00K, a 0.00% change from fiscal 2023.
- Vaxart, Inc. amortization of intangible assets for fiscal 2023 was $700.00K, a 46.15% decline from fiscal 2022.
- Vaxart, Inc. amortization of intangible assets for fiscal 2022 was $1.30M, a 23.53% decline from fiscal 2021.
- Vaxart, Inc. amortization of intangible assets for fiscal 2021 was $1.70M, a 0.00% change from fiscal 2020.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-06 | $400.00K 10-Q · filed 2026-08-06 | $600.00K derived: sum of 3 quarters · filed 2026-08-06 | $700.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $200.00K S-1 · filed 2026-05-08 | $400.00K derived: sum of 2 quarters · filed 2026-05-08 | $500.00K derived: sum of 3 quarters · filed 2026-05-08 | $700.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $200.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $300.00K derived: sum of 2 quarters · filed 2026-05-08 | $500.00K derived: sum of 3 quarters · filed 2026-08-06 | $700.00K S-1 · filed 2026-05-08 | ||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $300.00K derived: sum of 2 quarters · filed 2026-08-06 | $500.00K 10-Q · filed 2025-11-13 | $700.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $200.00K 10-Q · filed 2026-08-06 | $400.00K 10-Q · filed 2026-08-06 | $600.00K derived: sum of 3 quarters · filed 2026-08-06 | $700.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $200.00K 10-Q · filed 2025-05-13 | $400.00K derived: sum of 2 quarters · filed 2025-05-13 | $500.00K derived: sum of 3 quarters · filed 2025-11-13 | $700.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $300.00K derived: sum of 2 quarters · filed 2025-11-13 | $500.00K derived: sum of 3 quarters · filed 2025-11-13 | $700.00K 10-K · filed 2025-03-20 | ||||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-13 | $300.00K derived: sum of 2 quarters · filed 2025-11-13 | $500.00K 10-Q · filed 2025-11-13 | $700.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-13 | $400.00K 10-Q · filed 2025-08-13 | $600.00K derived: sum of 3 quarters · filed 2025-08-13 | $800.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-13 | $400.00K derived: sum of 2 quarters · filed 2025-05-13 | $600.00K derived: sum of 3 quarters · filed 2025-05-13 | $800.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $400.00K derived: sum of 2 quarters · filed 2025-03-20 | $600.00K derived: sum of 3 quarters · filed 2025-03-20 | $700.00K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-13 | $400.00K derived: sum of 2 quarters · filed 2024-11-13 | $500.00K 10-Q · filed 2024-11-13 | $900.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $200.00K 10-Q · filed 2024-08-08 | $183.00K 10-Q · filed 2023-08-03 | $400.00K 10-Q · filed 2024-08-08 | $366.00K 10-Q · filed 2023-08-03 | $700.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.00M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-13 | $183.00K 10-Q · filed 2023-05-04 | $500.00K derived: sum of 2 quarters · filed 2024-05-13 | $800.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.14M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $600.00K derived: sum of 2 quarters · filed 2024-03-14 | $937.00K derived: sum of 3 quarters · filed 2024-03-14 | $1.30M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $300.00K 10-Q · filed 2023-11-02 | $338.00K 10-Q · filed 2022-11-09 | $637.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.00M 10-Q · filed 2023-11-02 | $1.38M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | $337.00K 10-Q · filed 2023-08-03 | $675.00K 10-Q · filed 2023-08-03 | $1.07M derived: sum of 3 quarters · filed 2023-08-03 | $1.51M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $338.00K 10-Q · filed 2023-05-04 | $738.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.17M derived: sum of 3 quarters · filed 2023-05-04 | $1.60M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $833.00K derived: sum of 2 quarters · filed 2023-03-15 | $1.27M derived: sum of 3 quarters · filed 2023-03-15 | $1.70M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $433.00K 10-Q · filed 2022-11-09 | $866.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.30M 10-Q · filed 2022-11-09 | $1.70M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $433.00K 10-Q · filed 2022-08-08 | $866.00K 10-Q · filed 2022-08-08 | $1.27M derived: sum of 3 quarters · filed 2022-08-08 | $1.70M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $433.00K 10-Q · filed 2022-05-09 | $833.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.27M derived: sum of 3 quarters · filed 2022-05-09 | $1.70M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $833.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.27M derived: sum of 3 quarters · filed 2022-02-24 | $1.70M 10-K · filed 2022-02-24 | $1.73M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $433.00K 10-Q · filed 2021-11-04 | $866.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.30M 10-Q · filed 2021-11-04 | $1.30M 10-Q · filed 2020-11-12 | $1.71M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $433.00K 10-Q · filed 2021-08-05 | $866.00K 10-Q · filed 2021-08-05 | $1.28M derived: sum of 3 quarters · filed 2022-02-24 | $1.71M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $433.00K 10-Q · filed 2021-05-06 | $846.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.28M derived: sum of 3 quarters · filed 2022-02-24 | $1.95M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $846.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.52M derived: sum of 3 quarters · filed 2022-02-24 | $2.30M 10-K · filed 2022-02-24 | $2.32M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $433.00K 10-Q · filed 2020-11-12 | $1.11M derived: sum of 2 quarters · filed 2020-11-12 | $1.89M 10-Q · filed 2020-11-12 | $2.58M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $675.00K 10-Q · filed 2020-08-06 | $1.45M 10-Q · filed 2020-08-06 | $2.15M derived: sum of 3 quarters · filed 2021-02-25 | $2.96M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $779.00K 10-Q · filed 2020-05-12 | $1.48M derived: sum of 2 quarters · filed 2021-02-25 | $2.29M derived: sum of 3 quarters · filed 2021-02-25 | $3.09M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.51M derived: sum of 2 quarters · filed 2021-02-25 | $2.31M derived: sum of 3 quarters · filed 2021-02-25 | $2.73M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $812.00K 10-Q · filed 2019-11-12 | $1.62M derived: sum of 2 quarters · filed 2019-11-12 | $2.03M 10-Q · filed 2019-11-12 | $2.03M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $805.00K 10-Q · filed 2019-08-08 | $1.22M 10-Q · filed 2019-08-08 | $1.22M derived: sum of 3 quarters · filed 2019-08-08 | $1.22M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $413.00K 10-Q · filed 2019-05-09 | $414.00K derived: sum of 2 quarters · filed 2019-05-09 | $415.00K derived: sum of 3 quarters · filed 2019-05-09 | $416.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $2.00K derived: sum of 2 quarters · filed 2019-02-06 | $3.00K derived: sum of 3 quarters · filed 2019-02-06 | $4.00K 10-K · filed 2019-02-06 | ||||
| 2017-09-30 | $1.00K 10-Q · filed 2018-11-13 | $2.00K derived: sum of 2 quarters · filed 2018-11-13 | $3.00K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $1.00K 10-Q · filed 2018-08-10 | $2.00K 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | $1.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |